Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1084-65-7
2. Arresten
3. Fontiliz
4. 6-methylthiochroman-7-sulfonamide 1,1-dioxide
5. Sd 17102
6. 6-methyl-1,1-dioxo-3,4-dihydro-2h-thiochromene-7-sulfonamide
7. Nsc-759309
8. 2h-1-benzothiopyran-7-sulfonamide, 3,4-dihydro-6-methyl-, 1,1-dioxide
9. I7ekn1924q
10. Ncgc00016561-01
11. Sd-17102
12. Cas-1084-65-7
13. Meticranum [inn-latin]
14. 6-methylthiochromane-7-sulfonamide 1,1-dioxide
15. Dsstox_cid_25346
16. Dsstox_rid_80814
17. Dsstox_gsid_45346
18. Meticranum
19. Meticran
20. Meticrano
21. Meticrano [inn-spanish]
22. 2h-1-benzothiopyran-7-sulfonamide, 3,4-dihydro-6-methyl-, 1,1-dioxide (9ci)
23. 6-methylthiochroman-7-sulphonamide 1,1-dioxide;6-methylthiochroman-7-sulfonamide 1,1-dioxide
24. Meticrane [inn:dcf:jan]
25. Sr-01000838874
26. Einecs 214-112-4
27. E-103-e
28. Unii-i7ekn1924q
29. 6-methyl-7-sulfamido-thiochroman-1,1-dioxide
30. Arresten (tn)
31. Prestwick_881
32. Thiochroman-7-sulfonamide, 6-methyl-, 1,1-dioxide
33. Meticrane [inn]
34. Meticrane [jan]
35. Meticrane [mi]
36. Prestwick0_000011
37. Prestwick1_000011
38. Prestwick2_000011
39. Prestwick3_000011
40. 6-methyl-3,4-dihydro-2h-1-benzothiopyran-7-sulfonamide 1,1-dioxide
41. Meticrane (jp17/inn)
42. Meticrane [mart.]
43. Meticrane [who-dd]
44. Schembl49070
45. Bspbio_000041
46. Mls002154170
47. Meticrane, Analytical Standard
48. Spbio_001962
49. Bpbio1_000047
50. Zinc1718
51. Chembl1318341
52. Dtxsid9045346
53. Chebi:31839
54. Hms1568c03
55. Hms2095c03
56. Hms2235d06
57. Hms3371d22
58. Hms3712c03
59. Pharmakon1600-01506077
60. Baa08465
61. Hy-b0908
62. Tox21 110495
63. Tox21_110495
64. Mfcd00079454
65. Nsc759309
66. S4339
67. 6-methyl-1-thia-1,2,3,4-tetrahydronaphthalene-7-sulfonamide 1,1-dioxide
68. Akos016014038
69. Tox21_110495_1
70. Ccg-214046
71. Db13284
72. Nsc 759309
73. Ncgc00016561-02
74. Ncgc00016561-05
75. Bs-14410
76. Smr001233468
77. Sbi-0207038.p001
78. Ft-0725174
79. Sw197003-3
80. D01605
81. E75872
82. J-002149
83. Q6824077
84. Sr-01000838874-2
85. Sr-01000838874-3
86. Brd-k58265391-001-03-6
87. Brd-k58265391-001-06-9
88. 6-methyl-3,4-dihydro-2h-thiochromene-7-sulfonamide 1,1-dioxide
89. 3,4-dihydro-6-methyl-2h-1-benzothiopyran-7-sulfonamide 1,1-dioxide
Molecular Weight | 275.3 g/mol |
---|---|
Molecular Formula | C10H13NO4S2 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 275.02860024 g/mol |
Monoisotopic Mass | 275.02860024 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 485 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
C - Cardiovascular system
C03 - Diuretics
C03B - Low-ceiling diuretics, excl. thiazides
C03BA - Sulfonamides, plain
C03BA09 - Meticrane
ABOUT THIS PAGE
53
PharmaCompass offers a list of Meticrane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Meticrane manufacturer or Meticrane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Meticrane manufacturer or Meticrane supplier.
PharmaCompass also assists you with knowing the Meticrane API Price utilized in the formulation of products. Meticrane API Price is not always fixed or binding as the Meticrane Price is obtained through a variety of data sources. The Meticrane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prestwick3_000011 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prestwick3_000011, including repackagers and relabelers. The FDA regulates Prestwick3_000011 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prestwick3_000011 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prestwick3_000011 supplier is an individual or a company that provides Prestwick3_000011 active pharmaceutical ingredient (API) or Prestwick3_000011 finished formulations upon request. The Prestwick3_000011 suppliers may include Prestwick3_000011 API manufacturers, exporters, distributors and traders.
click here to find a list of Prestwick3_000011 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Prestwick3_000011 Drug Master File in Japan (Prestwick3_000011 JDMF) empowers Prestwick3_000011 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Prestwick3_000011 JDMF during the approval evaluation for pharmaceutical products. At the time of Prestwick3_000011 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Prestwick3_000011 suppliers with JDMF on PharmaCompass.
Prestwick3_000011 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prestwick3_000011 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prestwick3_000011 GMP manufacturer or Prestwick3_000011 GMP API supplier for your needs.
A Prestwick3_000011 CoA (Certificate of Analysis) is a formal document that attests to Prestwick3_000011's compliance with Prestwick3_000011 specifications and serves as a tool for batch-level quality control.
Prestwick3_000011 CoA mostly includes findings from lab analyses of a specific batch. For each Prestwick3_000011 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prestwick3_000011 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prestwick3_000011 EP), Prestwick3_000011 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prestwick3_000011 USP).